Reboxetine

This classification denotes an antidepressant agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 947S0YZ36I. European Medicines Agency schedules Reboxetine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB15112MIG. Reboxetine generally arises in the molecular formula C19H23NO3. The term REBOXETINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 40, no. 6, 1986, list 26.) REBOXETINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule reboxetine under HS 29349990 and SITC 51579. As of Q4 2014, REBOXETINE remains the US FDA Preferred Term for this commodity. Reboxetine bears US NLM identifiers UMLS ID C0168388 and NCI Concept Code C72838. SMILES: O1C(C(Oc2c(OCC)cccc2)c2ccccc2)CNCC1.